Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;49(3):1284-1288.
doi: 10.1007/s10803-018-3808-2.

Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study

Affiliations

Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study

Adi Aran et al. J Autism Dev Disord. 2019 Mar.

Abstract

Anecdotal evidence of successful cannabis treatment in autism spectrum disorder (ASD) are accumulating but clinical studies are lacking. This retrospective study assessed tolerability and efficacy of cannabidiol-rich cannabis, in 60 children with ASD and severe behavioral problems (age = 11.8 ± 3.5, range 5.0-17.5; 77% low functioning; 83% boys). Efficacy was assessed using the Caregiver Global Impression of Change scale. Adverse events included sleep disturbances (14%) irritability (9%) and loss of appetite (9%). One girl who used higher tetrahydrocannabinol had a transient serious psychotic event which required treatment with an antipsychotic. Following the cannabis treatment, behavioral outbreaks were much improved or very much improved in 61% of patients. This preliminary study supports feasibility of CBD-based cannabis trials in children with ASD.

Keywords: Autism spectrum disorder; Cannabidiol; Disruptive behavior; Medical cannabis; Medical marijuana.

PubMed Disclaimer

References

    1. Ment Retard Dev Disabil Res Rev. 2000;6(4):300-8 - PubMed
    1. Mol Autism. 2011 Jun 29;2(1):10 - PubMed
    1. J Psychopharmacol. 2012 Oct;26(10):1317-32 - PubMed
    1. J Autism Dev Disord. 2013 Apr;43(4):851-9 - PubMed
    1. JAMA Pediatr. 2013 Nov;167(11):1045-52 - PubMed